Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-04

FDA Approved: CARAFATE — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved Allergan's supplemental application for Carafate (sucralfate). This action updates the labeling and approved uses based on the submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARAFATE (sucralfate)

Snippet

SUPPL AP for CARAFATE (SUCRALFATE)